Our technology applications extend beyond public health to provide a broad range of actionable insights.
RIWI technology was first developed by a faculty member at the Dalla Lana School of Public Health at the University of Toronto to inform the Ontario government on how people across the world were protecting themselves against the H1N1 virus, and the extent to which they trusted government public health communications.
Now, RIWI’s data solutions extend across a spectrum of applications in public and private healthcare and life sciences. We ask healthcare consumers and healthcare professionals about their perspectives on changing products/services to improve health system access, pharmaceutical products and digital therapeutics, healthcare delivery and human rights. RIWI capabilities can also be leveraged to enhance clinical trial recruitment efforts, including the testing of clinical trial concepts and messaging, the evaluation of trial designs using RIWI data points and broadening the impact and reach of clinical studies to optimize resource utilization and efficiency relating to clinical trial recruitment processes.
RIWI is proud to help tackle issues aimed at improving health and well-being across geographies. This is referenced by work on vaccine hesitancy with the Global Health Crisis Coordination Center (GHC3)/Center for Disease Control (CDC), stigma surrounding vulnerable or under-represented groups such as drug users with Elevyst, and monitoring of public health security and testing public reaction to infectious diseases on a regional, national or global scale with the Fields Institute. Other clients include the World Food Programme, the International Displacement Monitoring Center and the Bill and Melinda Gates Foundation.